Literature DB >> 21458836

Human papillomavirus 16 E2 stability and transcriptional activation is enhanced by E1 via a direct protein-protein interaction.

Lauren E King1, Edward S Dornan, Mary M Donaldson, Iain M Morgan.   

Abstract

Human papillomavirus 16 E1 and E2 interact with cellular factors to replicate the viral genome. E2 forms homodimers and binds to 12 bp palindromic sequences adjacent to the viral origin and recruits E1 to the origin. E1 forms a di-hexameric helicase complex that replicates the viral genome. This manuscript demonstrates that E1 stabilises the E2 protein, increasing the half life in both C33a and 293 T cells respectively. This stabilisation requires a direct protein--protein interaction. In addition, the E1 protein enhances E2 transcription function in a manner that suggests the E1 protein itself can contribute to transcriptional regulation not simply by E2 stabilisation but by direct stimulation of transcription. This activation of E2 transcription is again dependent upon an interaction with E1. Overall the results suggest that in the viral life cycle, co-expression of E1 with E2 can increase E2 stability and enhance E2 function.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458836     DOI: 10.1016/j.virol.2011.03.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Uncovering the Role of the E1 Protein in Different Stages of Human Papillomavirus 18 Genome Replication.

Authors:  Alla Piirsoo; Martin Kala; Eve Sankovski; Mart Ustav; Marko Piirsoo
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

2.  The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2.

Authors:  Dipon Das; Nathan Smith; Xu Wang; Iain M Morgan
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

3.  An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment.

Authors:  Mary M Donaldson; Lorna J Mackintosh; Jason M Bodily; Edward S Dornan; Laimonis A Laimins; Iain M Morgan
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

4.  Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication.

Authors:  Elaine J Gauson; Mary M Donaldson; Edward S Dornan; Xu Wang; Molly Bristol; Jason M Bodily; Iain M Morgan
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

Review 5.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

6.  Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification.

Authors:  Tormi Reinson; Mart Toots; Meelis Kadaja; Regina Pipitch; Mihkel Allik; Ene Ustav; Mart Ustav
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

Review 7.  The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology.

Authors:  Van G Wilson
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

8.  The Cellular DNA Helicase ChlR1 Regulates Chromatin and Nuclear Matrix Attachment of the Human Papillomavirus 16 E2 Protein and High-Copy-Number Viral Genome Establishment.

Authors:  Leanne Harris; Laura McFarlane-Majeed; Karen Campos-León; Sally Roberts; Joanna L Parish
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

9.  Stochastic modeling of human papillomavirusearly promoter gene regulation.

Authors:  Alberto Giaretta; Gianna Maria Toffolo; Timothy C Elston
Journal:  J Theor Biol       Date:  2019-10-28       Impact factor: 2.691

10.  The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.

Authors:  Abida Siddiqa; Karen Campos Léon; Claire D James; Muhammad Faraz Bhatti; Sally Roberts; Joanna L Parish
Journal:  J Gen Virol       Date:  2015-04-24       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.